TrialBlood advances2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study.
Filippo Milano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it